Free Submission Public Relations &
Deutsch English

DiaKine Therapeutics, Inc. - Product Pipeline Review - 2012

DiaKine Therapeutics, Inc. - Product Pipeline Review - 2012 - new company profile report published

Print article Print article
2012-12-14 03:38:13 - DiaKine Therapeutics, Inc. - Product Pipeline Review - 2012 - a new company profile report on

DiaKine Therapeutics, Inc. - Product Pipeline Review - 2012 - This pharmaceuticals report, "DiaKine Therapeutics, Inc. - Product Pipeline Review - 2012" provides data on the DiaKine Therapeutics, Inc.´s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from our proprietary databases, DiaKine Therapeutics, Inc.´s corporate website, SEC filings, investor presentations and featured press releases, both from DiaKine Therapeutics, Inc. and industry-specific third party sources, put together by This team.


- DiaKine Therapeutics, Inc. - Brief DiaKine Therapeutics, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline



of DiaKine Therapeutics, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of DiaKine Therapeutics, Inc. with complete description of the product´s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the DiaKine Therapeutics, Inc.´s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate DiaKine Therapeutics, Inc.´s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of DiaKine Therapeutics, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the DiaKine Therapeutics, Inc.´s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with DiaKine Therapeutics, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of DiaKine Therapeutics, Inc. and identify potential opportunities in those areas.


Current R&D Portfolio of DiaKine Therapeutics, Inc.; DiaKine Therapeutics, Inc. - Key Therapeutics; DiaKine Therapeutics, Inc. - Pipeline Overview and Promising Molecules; DiaKine Therapeutics, Inc. - News; DiaKine Therapeutics, Inc. - Latest Updates; DiaKine Therapeutics, Inc. - Pipeline; DiaKine Therapeutics, Inc. - Discontinued/Dormant Projects

Click for report details: ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Latest Company Profile Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Mike King
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact | BidVertiser